Compare ALEMBIC LTD with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs WOCKHARDT - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD WOCKHARDT ALEMBIC LTD/
WOCKHARDT
 
P/E (TTM) x 70.0 -19.8 - View Chart
P/BV x 2.5 1.0 238.1% View Chart
Dividend Yield % 0.4 0.0 11,105.6%  

Financials

 ALEMBIC LTD   WOCKHARDT
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
WOCKHARDT
Mar-18
ALEMBIC LTD/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs721,012 7.1%   
Low Rs34532 6.4%   
Sales per share (Unadj.) Rs4.7355.9 1.3%  
Earnings per share (Unadj.) Rs6.1-60.3 -10.1%  
Cash flow per share (Unadj.) Rs6.2-46.8 -13.4%  
Dividends per share (Unadj.) Rs0.200.01 2,000.0%  
Dividend yield (eoy) %0.40 29,150.1%  
Book value per share (Unadj.) Rs40.7257.8 15.8%  
Shares outstanding (eoy) m267.03110.63 241.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.2 519.4%   
Avg P/E ratio x8.7-12.8 -67.8%  
P/CF ratio (eoy) x8.5-16.5 -51.4%  
Price / Book Value ratio x1.33.0 43.5%  
Dividend payout %3.30 -19,751.4%   
Avg Mkt Cap Rs m14,13985,379 16.6%   
No. of employees `000NA6.3 0.0%   
Total wages/salary Rs m2079,371 2.2%   
Avg. sales/employee Rs ThNM6,295.0-  
Avg. wages/employee Rs ThNM1,498.3-  
Avg. net profit/employee Rs ThNM-1,066.3-  
INCOME DATA
Net Sales Rs m1,25539,369 3.2%  
Other income Rs m3701,202 30.8%   
Total revenues Rs m1,62540,571 4.0%   
Gross profit Rs m11118 607.1%  
Depreciation Rs m381,495 2.5%   
Interest Rs m22,555 0.1%   
Profit before tax Rs m442-2,830 -15.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m24257 9.3%   
Profit after tax Rs m1,630-6,669 -24.4%  
Gross profit margin %8.90 19,041.6%  
Effective tax rate %5.4-9.1 -59.7%   
Net profit margin %129.8-16.9 -766.6%  
BALANCE SHEET DATA
Current assets Rs m1,86733,796 5.5%   
Current liabilities Rs m59126,917 2.2%   
Net working cap to sales %101.617.5 581.8%  
Current ratio x3.21.3 251.5%  
Inventory Days Days9479 118.8%  
Debtors Days Days7489 82.4%  
Net fixed assets Rs m1,79139,664 4.5%   
Share capital Rs m534553 96.5%   
"Free" reserves Rs m10,32427,968 36.9%   
Net worth Rs m10,85828,522 38.1%   
Long term debt Rs m4121,731 0.2%   
Total assets Rs m11,59181,620 14.2%  
Interest coverage x260.9-0.1 -242,638.6%   
Debt to equity ratio x00.8 0.5%  
Sales to assets ratio x0.10.5 22.5%   
Return on assets %14.1-5.0 -279.3%  
Return on equity %15.0-23.4 -64.2%  
Return on capital %15.2-7.7 -197.9%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m199,807 0.2%   
Fx outflow Rs m2641,789 14.8%   
Net fx Rs m-2448,019 -3.0%   
CASH FLOW
From Operations Rs m236684 34.5%  
From Investments Rs m-2246,302 -3.6%  
From Financial Activity Rs m-27-7,695 0.3%  
Net Cashflow Rs m-15-664 2.2%  

Share Holding

Indian Promoters % 64.0 74.5 85.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 2.3 8.7%  
FIIs % 9.7 7.7 126.0%  
ADR/GDR % 0.0 0.1 -  
Free float % 26.1 15.4 169.5%  
Shareholders   54,701 67,757 80.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON   

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Realty and Telecom Stocks Drag(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is flat while the Hang Seng is down 0.9%.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Oct 23, 2019 10:37 AM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - VENUS REMEDIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS